Carlisle director Jonathan Collins sells $540K in shares

The securities listed trace to RSU vesting on April 29, 2026, April 30, 2025, and May 2, 2024.

Accepted by SEC EDGAR 05/05/2026 - 05:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Director Jonathan Collins sold 1,543 shares of Carlisle Companies Inc (CSL) common stock on May 1, 2026; the reported aggregate market value was $540,050. The securities listed include 785 shares acquired through RSU vesting on April 29, 2026, 451 shares on April 30, 2025, and 307 shares on May 2, 2024.

Key Figures

Common shares sold: 1,543 shares Aggregate market value: $540,050 Shares acquired through RSU vesting: 785 shares +2 more

5 metrics

Common shares sold 1,543 shares Sale on May 1, 2026

Aggregate market value $540,050 Shares reported sold on May 1, 2026

Shares acquired through RSU vesting 785 shares April 29, 2026

Shares acquired through RSU vesting 451 shares April 30, 2025

Shares acquired through RSU vesting 307 shares May 2, 2024

Key Terms

RSU Vesting, Aggregate Market Value, attorney-in-fact

3 terms

RSU Vesting financial

"Nature of Acquisition Transaction: RSU Vesting"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

Aggregate Market Value financial

"Number of Shares or Other Units To Be Sold | Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact technical

"as attorney-in-fact for Jonathan Collins"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CSL shares did director Jonathan Collins sell?

Jonathan Collins reported a sale of 1,543 Carlisle Companies Inc common shares on May 1, 2026, with an aggregate market value of $540,050.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001683884
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CARLISLE COMPANIES INC
SEC File Number	001-09278
Address of Issuer	16430 N. SCOTTSDALE RD., SUITE 400 Scottsdale ARIZONA 85254
Phone	480-781-5000
Name of Person for Whose Account the Securities are To Be Sold	Jonathan Collins
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	1543	540050	40470000	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/29/2026	RSU Vesting	Issuer			785	04/29/2026	N/A
Common Stock	04/30/2025	RSU Vestuin	Issuer			451	04/30/2025	N/A
Common Stock	05/02/2024	RSU Vesting	Issuer			307	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This filing is for shares that were sold on 05/01/2026.
Date of Notice	05/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Jonathan Collins
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)